Search Results - "Sandrim, Valéria C."
-
1
Potential roles of visfatin/NAMPT on endothelial dysfunction in preeclampsia and pathways underlying cardiac and vascular remodeling
Published in Journal of cellular physiology (01-01-2022)Get full text
Journal Article -
2
Circulating levels of tissue inhibitor of metalloproteinase 3, a protein with inhibitory effects on angiogenesis, are increased in pre‐eclampsia
Published in International journal of gynecology and obstetrics (01-05-2023)“…Objective To assess and compare circulating tissue inhibitor of metalloproteinase 3 (TIMP‐3) concentrations between women with pre‐eclampsia and healthy…”
Get full text
Journal Article -
3
Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia
Published in Hypertension research (01-08-2019)“…In this study, we demonstrated that plasma collected from women who subsequently developed preeclampsia caused increased heme oxygenase-1 (HO-1) production and…”
Get full text
Journal Article -
4
Amino Acid Biosignature in Plasma among Ischemic Stroke Subtypes
Published in BioMed research international (01-01-2019)“…Ischemic stroke is a neurovascular disorder caused by reduced or blockage of blood flow to the brain, which may permanently affect motor and cognitive…”
Get full text
Journal Article -
5
Higher levels of circulating TIMP-4 in preeclampsia is strongly associated with clinical parameters and microRNA
Published in Clinical and experimental hypertension (1993) (03-10-2018)“…Background: Preeclampsia results in maternal and fetal complications and some studies have reported the role of MMPs and TIMPs in its pathophysiology…”
Get full text
Journal Article -
6
Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia
Published in Nitric oxide (15-11-2014)“…•NO pathway seems to play a central role in uteroplacental changes during pregnancy.•Preeclampsia (PE) is associated with endothelial dysfunction.•Polymorphism…”
Get full text
Journal Article -
7
4G/5G polymorphism modulates PAI-1 circulating levels in obese women
Published in Molecular and cellular biochemistry (01-05-2012)“…The increase in plasminogen activator inhibitor type 1 (PAI-1) has been described as a risk factor to thrombosis-related diseases. In addition, it has been…”
Get full text
Journal Article -
8
Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects
Published in Molecular and cellular biochemistry (01-01-2012)“…Deficient formation of endogenous nitric oxide (NO) contributes to cardiovascular diseases, and this may be associated with increased circulating levels of…”
Get full text
Journal Article -
9
Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression
Published in Pharmacogenomics (01-07-2016)“…Over 40% of patients with pre-eclampsia are nonresponsive to antihypertensive therapy, but the underlying mechanisms are unknown. We examined the effects of…”
Get full text
Journal Article -
10
Preeclamptic plasma stimulates the expression of miRNAs, leading to a decrease in endothelin-1 production in endothelial cells
Published in Pregnancy hypertension (01-04-2018)“…•In vitro endothelin-1 levels are increased before onset of preeclampsia symptoms.•In vitro endothelin-1 levels are similar after onset of preeclampsia…”
Get full text
Journal Article -
11
NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia
Published in Pregnancy hypertension (01-10-2019)“…•Plasma NAMPT and nitrite levels are positively related in healthy pregnant.•Plasma NAMPT and nitrite levels are inversely related in preeclampsia.•Plasma…”
Get full text
Journal Article -
12
Homocysteine and nitrite levels are modulated by MTHFR 677C>T polymorphism in obese women treated with simvastatin
Published in Clinical and experimental pharmacology & physiology (01-10-2014)“…Summary Higher homocysteine (Hcy) levels are associated with cardiovascular risk. The aim of the present study was to evaluate the effect of simvastatin…”
Get full text
Journal Article -
13
Anti-inflammatory effects of atorvastatin: Modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene
Published in Atherosclerosis (01-08-2007)“…Abstract Statins produce cholesterol-independent, anti-inflammatory effects, which result at least in part from increased endothelial nitric oxide production…”
Get full text
Journal Article -
14
Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus
Published in Atherosclerosis (01-11-2006)“…Type 2 diabetes mellitus (T2DM) and hypertension (HT) commonly coexist. While endothelial nitric oxide synthase (eNOS) haplotypes have been associated with HT,…”
Get full text
Journal Article -
15
Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy
Published in Journal of hypertension (01-12-2006)“…OBJECTIVESMost hypertensive patients require two or more drugs to control arterial blood pressure effectively. Although endothelial nitric oxide synthase…”
Get full text
Journal Article -
16
Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus
Published in Blood coagulation & fibrinolysis (01-03-2015)“…Type 2 diabetes mellitus (DM2) is a metabolic disorder associated with hyperactivation of platelets, increased formation of platelet microparticles (PMPs) and…”
Get full text
Journal Article -
17
Visfatin levels are decreased in advanced stages of diabetic nephropathy
Published in Renal failure (21-10-2015)Get more information
Journal Article -
18
Different Proteomic Profiles Regarding Antihypertensive Therapy in Preeclampsia Pregnant
Published in International journal of molecular sciences (10-08-2024)“…Preeclampsia (PE) is a hypertensive pregnancy syndrome associated with target organ damage and increased cardiovascular risks, necessitating antihypertensive…”
Get full text
Journal Article -
19
Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes
Published in International journal of molecular sciences (08-01-2021)“…Previous studies have described increased circulating cell-free DNA (cfDNA) in hypertensive disorders of pregnancy (HDP). Here, we aimed first to confirm this…”
Get full text
Journal Article -
20
Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions
Published in Frontiers in pharmacology (28-02-2018)“…Hypertension is a leading cause of cardiovascular mortality, but only about half of patients on antihypertensive therapy achieve blood pressure control…”
Get full text
Journal Article